Anticoagulation shows no benefit after primary percutaneous coronary intervention, says research

by

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session August 28 at ESC Congress 2023.

Leave A Comment

Your email address will not be published. Required fields are marked *